Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 145
Number of items: 145
  • Drion, C. M., Borm, L. E., Kooijman, L., Aronica, E., Wadman, W. J., Hartog, A. F., van Vliet, E. A., & Gorter, J. A. (2016). Effects of rapamycin and curcumin treatment on the development of epilepsy after electrically induced status epilepticus in rats. Epilepsia, 57(5), 688-697. https://doi.org/10.1111/epi.13345
  • van Scheppingen, J., Lyer, A. M., Prabowo, A. S., Mühlebner, A., Anink, J. J., Scholl, T., Feucht, M., Jansen, F. E., Spliet, W. G., Kresk, P., Zamecnik, J., Buccoliero, A. M., Giordano, F., Genitori, L., Kotulska, K., Jozwiak, S., Jaworski, J., Liszewska, E., van Vliet, E. A., & Aronica, E. (2016). Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures. GLIA, 64(6), 1066-1082. https://doi.org/10.1002/glia.22983
  • van Vliet, E. A., Otte, W. M., Wadman, W. J., Aronica, E., Kooij, G., de Vries, H. E., Dijkhuizen, R. M., & Gorter, J. A. (2016). Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging. Epilepsia, 57(1), 59-69. https://doi.org/10.1111/epi.13246
  • van Vliet, E. A., Otte, W. M., Wadman, W. J., Aronica, E., Kooij, G., de Vries, H. E., Dijkhuizen, R. M., & Gorter, J. A. (2016). Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms. Epilepsia, 57(1), 70-78. https://doi.org/10.1111/epi.13245
  • Shen, H.-Y., van Vliet, E. A., Bright, K.-A., Hanthorn, M., Lytle, N. K., Gorter, J., Aronica, E., & Boison, D. (2015). Glycine transporter 1 is a target for the treatment of epilepsy. Neuropharmacology, 99, 554-565. https://doi.org/10.1016/j.neuropharm.2015.08.031
  • van Vliet, E. A., Aronica, E., & Gorter, J. A. (2015). Blood-brain barrier dysfunction, seizures and epilepsy. Seminars in Cell & Developmental Biology, 38, 26-34. https://doi.org/10.1016/j.semcdb.2014.10.003
  • Gorter, J. A., van Vliet, E. A., & Aronica, E. (2015). Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis. Epilepsy & Behavior, 49, 13-16. https://doi.org/10.1016/j.yebeh.2015.04.047
  • van Vliet, E. A., Aronica, E., & Gorter, J. A. (2014). Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance. Neuroscience, 277, 455-473. https://doi.org/10.1016/j.neuroscience.2014.07.030
  • Zellinger, C., Salvamoser, J. D., Soerensen, J., van Vliet, E. A., Aronica, E., Gorter, J., & Potschka, H. (2014). Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701, 324 improves pharmacosensitivity in a mouse kindling model. Epilepsy Research, 108(4), 634-643. https://doi.org/10.1016/j.eplepsyres.2014.02.012
  • Holtman, L., van Vliet, E., Appeldoorn, C., Gaillard, P. J., de Boer, M., Dorland, R., Wadman, W., & Gorter, J. (2014). Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat. Epilepsy Research, 108(3), 396-404. https://doi.org/10.1016/j.eplepsyres.2014.01.010
Page 9 of 15